Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1243-1247

  Elias, Lucila L K ^a   Antunes Rodrigues, José ^a   Elias, Paula C L ^a   Moreira, Ayrton C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; FEMALE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MALE; PLASMA OSMOLALITY; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; DIABETES INSIPIDUS; FEMALE; HUMANS; HYDROCORTISONE; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PITUITARY-ADRENAL SYSTEM; SALINE SOLUTION, HYPERTONIC; SODIUM CHLORIDE;

EID: 0030905071     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1243     Document Type: Article

References (36)

1. Vale W, Spiess J, Rivier C, Rivier J. 1981 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science. 213:1394-1397.
2. Jones MT, Gillham B. 1988 Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol Rev. 68:743-818.
3. Gillies GE, Linton EA, Lowry PJ. 1982 Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature. 299:355-357.
4. Debold CR, Sheldon WR, Decherney GS, et al. 1984 Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 73:533-538.
5. Arai K, Takebe K. 1991 Corticotropin response to combined administration of human corticotropin-releasing hormone and small-dose arginine vasopressin in normal, subjects. Metabolism. 40:1088-1091.
6. Milsom RS, Conaglen JV, Donald RA, Espiner EA, Nicholls MG, Livesey JH. 1985 Augmentation of the response to the CRF in man: relative contributions of endogenous angiotensin and vasopressin. Clin Endocrinol (Oxf). 22:623-628.
7. Rittmaster RS, Cutler, Jr, GB, Gold PW, et al. 1987 The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab. 64:371-376.
8. Watabe T, Tanaka K, Kumagae M, et al. 1988 Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man. J Clin Endocrinol Metab. 66:1132-1137.
9. McCann SM, Antunes-Rodrigues J, Nallar R, Valtin H. 1966 Pituitary-adrenal function in the absence of vasopressin. Endocrinology. 79:1958-1064.
10. Buckingham JC, Leach JH. 1980 Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus. J Physiol. 305:397-404.
11. Bisset GW, Chowrey HS. 1988 Control of release of vasopressin by neuroendocrine reflexes. Q J Exp Physiol. 73:811-872.
12. Imura H, Nakao K, Itoh H. 1992 The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front Neuroendocrinol. 13:217-249.
13. Samson WK. 1985 Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology. 40:277-279.
14. Clark BA, Elahi D, Fish L, et al. 1991 Atrial natriuretic peptide suppresses osmostimulated vasopressin release in young and elderly humans. Am J Physiol. 261:E252-E256.
15. Thrasher TN, Ramsay DJ. 1993 Interactions between vasopressin and atrial natriuretic peptides. Ann NY Acad Sci. 689:426-437.
16. Palkovits M, Eskay RL, Antoni FA. 1987 Atrial natriuretic peptide in the median eminence is of paraventricular nucleus origin. Neuroendocrinology. 46:542-544.
17. Lim AT, Sheward WJ, Copolov D, Windmill D, Fink G. 1990 Atrial natriuretic factor is released into hypophysial portal blood: direct evidence that atrial natriuretic factor may be a neurohormone involved in hypothalamic pituitary control. J Neuroendocrinol. 2:15-18.
18. Dayanithi G, Antoni FA. 1989 Atriopeptins are potent inhibitors of ACTH secretion by rat anterior pituitary cells in vitro: involvement of the atrial natriuretic factor receptor domain of membrane-bound guanylyl cyclase. J Endocrinol. 125:39-44.
19. Franci CR, Anselmo-Franci JA, McCann SM. 1992 The role of endogenous atrial natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Proc Natl Acad Sci USA. 89:11391-11395.
20. Miller M, Dalakos T, Moses AM, Fellerman H, Streeten DHP. 1970 Recognition of partial defects in antidiuretic hormone secretion. Ann Int Med. 73:721-729.
21. Moreira AC, Barizon EA, Silva JR. 1987 Standardization of a radioimmunoassay for plasma ACTH. Arq Bras Endocrinol Metab. 31:19-22.
22. Vieira JGH. 1977 Radioimmunoassay of serum Cortisol. MA thesis. São Paulo: Escola Paulista de Medicina; 1-67.
23. Glick SM, Kagan A. 1979 Vasopressin. In: Jaffe BM, Behrman HR, (eds) Methods of Hormone Radioimmunoassay, ed 2. New York: Academic Press; 341-351.
24. Gutkowska J, Horky K, Thibault G, Januszewicz P, Cantin M, Genest J. 1984 Atrial natriuretic factor is a circulating hormone. Biochem Biophys Res Commun. 30:315-323.
25. Mazza E, Goffi S, Barchi P, et al. 1994 Enhanced adrenocorticotrophic hormone and cortisol responses to corticotrophin-releasing hormone in central diabetes insipidus. Eur J Endocrinol. 130:121-124.
26. Green JR, Buchan GC, Alvord, Jr, EC, Swanson AG. 1967 Hereditary and idiopathic types of diabetes insipidus. Brain. 90:707-714.
27. Holmes MC, Catt KJ, Aguilera G. 1987 Involvement of vasopressin in the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy. Endocrinology. 121:2093-2098.
28. Balment RJ, Brimble MJ, Forsling ML. 1982 Oxytocin release and renal action in normal and Brattleboro rats. Ann NY Acad Sci. 394:241-253.
29. Nussey SS, Ang VTY, Finer N, Jenkins JS. 1986 Responses of neurohypophysial peptides to hypertonic saline and insulin-induced hypoglycemia in man. Clin Endocrinol (Oxf). 24:97-105.
30. Williams TDM, Abel DC, King CMP, Jelley RY, Lightman SL. 1986 Vasopressin and oxytocin responses to acute and chronic osmotic stimuli in man. J Endocrinol. 108:163-168.
31. Spinedi E, Negro-Vilar A. 1983 Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Neuroendocrinology. 37:446-453.
32. Antaraki A, Rangou D, Chlouverakis C. 1994 The renin-aldosterone axis in patients with diabetes insipidus. Clin Endocrinol (Oxf). 40:505-510.
33. Ruskoaho H. 1992 Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev. 44:479-602.
34. Kamoi K, Ebe T, Kobayashi O, et al. 1990 Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus. J Clin Endocrinol Metab. 70:1385-1390.
35. Antunes-Rodrigues J, Ramalho MJ, Reis LC, et al. 1991 Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide. Proc Natl Acad Sci USA. 88:2956-2960.
36. Haanwinckel MA, Elias LLK, Favaretto ALV, Gutkowska J, McCann SM, Antunes-Rodrigues J. 1995 Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA. 92:7902-7906.